Biologics Outsourcing Services Market - Forecasts from 2025 to 2030

The biologics outsourcing services market will grow at a CAGR of 11.37% to be valued at US$35.89 billion in 2030 from US$20.945 billion in 2025.

Biologics are essentially the drugs procured from living organisms or those which consist of the components of living organisms. These drugs are further used for the treatment of a range of diseases such as chronic diseases, cancer, cardiovascular diseases, etc. They are composed of sugar, proteins, and nucleic acid. When compared to small molecule drugs, biologics are much costlier but provide better results to the patient.

The biologics outsourcing market is experiencing growth primarily due to the increasing demand for research and development and advancements in biologic therapeutics. Biologic therapeutics are viewed as the future of medical solutions, with many countries focusing on co-formulation strategies to enhance compliance, convenience, and efficacy. Rising investments and competitive dynamics are expected to fuel market demand during the forecast period.

Numerous companies are channeling significant investments into the biologics outsourcing market globally. The market is segmented into North America, Europe, South America, and Asia Pacific, with North America leading due to substantial investments. The Asia Pacific region is the fastest-growing, driven by large populations, low-cost drug manufacturing, and increasing investments. Europe is also poised for growth with expanding investment activities.

Competition in the biologics outsourcing industry is intensifying, with the US holding the largest market share. Countries like India and China are gaining a competitive advantage by offering lower costs. Key players include Eurofins Scientific SE, WuXi AppTec, Lonza Group Ltd, SGS SA, and others. The market is further propelled by the rising prevalence of chronic diseases, an aging population, and growing investments.

Some of the major players covered in this report include Lonza Group AG, WuXi Biologics, Catalent Inc., Samsung Biologics Co., Ltd., Boehringer Ingelheim BioXcellence, Fujifilm Diosynth Biotechnologies, AbbVie Contract Manufacturing, Thermo Fisher Scientific Inc., AGC Biologics, and Recipharm AB among others.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Biologics Outsourcing Services Market Segmentations:

Biologics Outsourcing Services Market Segmentation by service type:

• The market is analyzed by the following service types:
• Drug Development Services:
• Cell Line Development
• Process Optimization
• Analytical Testing
• Manufacturing Services:
• Drug Substance Manufacturing
• Fill/Finish Operations
• Biosimilar Production
• Regulatory & Compliance Services
• Clinical Research Services:
• Preclinical Studies
• Phase I-IV Trials
• Supply Chain & Logistics Services

Biologics Outsourcing Services Market Segmentation by molecule type:

• The report analyzes the market by molecule type:
• Monoclonal Antibodies (mAbs)
• Recombinant Proteins
• Vaccines
• Cell & Gene Therapies
• Others

Biologics Outsourcing Services Market Segmentation by end-user:

The market is segmented by end-user:

• Pharmaceutical Companies
• Biotechnology Firms
• Academic & Research Institutions

Biologics Outsourcing Services Market Segmentation by regions:

The study also analyzed the biologics outsourcing services market into the following regions, with country-level forecasts and analysis as below:

• North America (US, Canada, and Mexico)
• South America (Brazil, Argentina, and Others)
• Europe (Germany, UK, France, Spain, and Others
• Middle East and Africa (Saudi Arabia, UAE, and Others)
• Asia Pacific (China, Japan, India, South Korea, Thailand, Indonesia, and Others)

Biologics Outsourcing Services Market Report Coverage:

This report provides extensive coverage as explained in the points below:

• Biologics Outsourcing Services Market Size, Forecasts, and Trends by Service Type: Historical revenue data and analysis focusing on adoption based on service type.
• Biologics Outsourcing Services Market Size, Forecasts, and Trends by Molecule Type and End-User.
• The Biologics outsourcing services market is also analyzed across different regions, with historical data, regional share, attractiveness, and opportunity of these solutions in different countries. The growth prospects and key players operating in these markets. The section also dwells on the macro factors, economic scenario, and other complementary factors aiding in market growth.
• Market dynamics: The section details the market growth factors, restraints, and opportunities in the market. The segment also presents a complete market scenario with the help of Porter's five forces model.
• Competitive Intelligence: A thorough investigation of the competitive structure of the market presented through a proprietary vendor matrix model, market share analysis of key players, insights on strategies of key players, and recent major developments undertaken by the companies to gain a competitive edge.
• Research methodology: The assumptions and sources that were considered to arrive at the final market estimates. Additionally, how our model is refined to ensure the most significant factors are taken into consideration with the proper hypothesis and bottom-up and top-down approaches enhance the reliability of forecasts further strengthening the trustworthiness of the numbers being presented.

How this report is helpful to you and reasons for the purchase?

• The report provides a strategic outlook of the biologics outsourcing services market to the decision-makers, analysts, and other stakeholders in the easy-to-read format for making informed decisions.
• The charts, tables, and figures make it easy for the executives to gain valuable insights while skimming the report.
• Analyst support through calls and emails for timely clarification and incorporating additional requests.
• Option of presentation or doc format with the estimates file to take care of diverse requirements.
• 15% FREE customization with all our reports to help cater to additional requirements with significant cost savings.
• Option of purchasing specific segments of the study, including opting for summary reports or just the estimates file.